Validation of Addiction Severity Index (ASI) for Assessment of Psychiatric Comorbidity in Multi-Site Randomized Controlled Trials

References

• Alterman, A. I., McDermott, P. A., Cook, T. G., Metzger, D., Rutherford, M. J., Cacciola, J. S., & Brown Jr, L. S. (1998). New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent. Psychology of Addictive Behaviors, 12(4), 233–246. doi:10.1037/0893-164X.12.4.233
   Web of Science ®Google Scholar
• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association.
   Google Scholar
• Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., … Motevalian, A. (2016). Epidemiology of illicit drug use disorders in Iran: Prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction, 111(10), 1836–1847. doi:10.1111/add.13453
   PubMed Web of Science ®Google Scholar
• Bewick, V., Cheek, L., & Ball, J. (2004). Statistics review 13: Receiver operating characteristic curves. Critical Care, 8(6), 508–512. doi:10.1186/cc3000
   PubMed Web of Science ®Google Scholar
• Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being. Drug and Alcohol Dependence, 68(3), 299–307. doi:10.1016/S0376-8716(02)00220-X
   PubMed Web of Science ®Google Scholar
• Cacciola, J. S., Alterman, A. I., Habing, B., & McLellan, A. T. (2011). Recent status scores for version 6 of the Addiction Severity Index (ASI-6). Addiction, 106(9), 1588–1602. doi:10.1111/j.1360-0443.2011.03482.x
   PubMed Web of Science ®Google Scholar
• Cacciola, J. S., Pecoraro, A., & Alterman, A. I. (2008). Development of ASI psychiatric severity cut-off scores to identify co-occurring psychiatric disorders. International Journal of Mental Health and Addiction, 6(1), 77–92. doi:10.1007/s11469-007-9103-7
   Google Scholar
• Calsyn, D. A., Saxon, A. J., Bush, K. R., Howell, D. N., Baer, J. S., Sloan, K. L., … Kivlahan, D. R. (2004). The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: Concurrent and discriminant validity. Drug and Alcohol Dependence, 76(2), 165–171. doi:10.1016/j.drugalcdep.2004.04.018
   PubMed Web of Science ®Google Scholar
• Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67(2), 247–257. doi:10.4088/JCP.v67n0211
   PubMed Web of Science ®Google Scholar
• Dagher, R. K., & Green, K. M. (2015). Does depression and substance abuse co-morbidity affect socioeconomic status? Evidence from a prospective study of urban African Americans. Psychiatry Research, 225(1-2), 115–121. doi:10.1016/j.psychres.2014.10.026
   PubMed Web of Science ®Google Scholar
• De Alwis, D., Lynskey, M. T., Reiersen, A. M., & Agrawal, A. (2014). Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addictive Behaviors, 39(8), 1278–1285. doi:10.1016/j.addbeh.2014.04.003
   PubMed Web of Science ®Google Scholar
• DeMarce, J. M., Lash, S. J., Stephens, R. S., Grambow, S. C., & Burden, J. L. (2008). Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment. Addictive Behaviors, 33(9), 1104–1112. doi:10.1016/j.addbeh.2008.02.008
   PubMed Web of Science ®Google Scholar
• Drake, R. E., Mueser, K. T., Clark, R. E., & Wallach, M. A. (1996). The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry, 66(1), 42–51. doi:10.1037/h0080153
   PubMed Web of Science ®Google Scholar
• Drymalski, W. M., & Nunley, M. R. (2016). The use of the Addiction Severity Index psychiatric composite scores to predict psychiatric inpatient admissions. Journal of Addictions Nursing, 27(3), 190–196. doi:10.1097/JAN.0000000000000134
   PubMed Web of Science ®Google Scholar
• Fischer, J. E., Bachmann, L. M., & Jaeschke, R. (2003). A readers’ guide to the interpretation of diagnostic test properties: Clinical example of sepsis. Intensive Care Medicine, 29(7), 1043–1051. doi:10.1007/s00134-003-1761-8
   PubMed Web of Science ®Google Scholar
• Gates, M. L., Turney, A., Ferguson, E., Walker, V., & Staples-Horne, M. (2017). Associations among substance use, mental health disorders, and self-harm in a prison population: Examining group risk for suicide attempt. International Journal of Environmental Research and Public Health, 14(3), E317. doi:10.3390/ijerph14030317
   PubMed Web of Science ®Google Scholar
• Greenfield, S. F., Rosa, C., Putnins, S. I., Green, C. A., Brooks, A. J., Calsyn, D. A., … Winhusen, T. (2011). Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A summary of findings. American Journal of Drug and Alcohol Abuse, 37(5), 301–312. doi:10.3109/00952990.2011.596875
   PubMed Web of Science ®Google Scholar
• Greiner, M., Pfeiffer, D., & Smith, R. D. (2000). Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Preventive Veterinary Medicine, 45(1–2), 23–41. doi:10.1016/S0167-5877(00)00115-X
   PubMed Web of Science ®Google Scholar
• Han, B., Compton, W. M., Blanco, C., & Colpe, L. J. (2017). Prevalence, treatment, and unmet treatment needs of us adults with mental health and substance use disorders. Health Affairs, 36(10), 1739–1747. doi:10.1377/hlthaff.2017.0584
   PubMed Web of Science ®Google Scholar
• Hartz, S. M., Pato, C. N., Medeiros, H., Cavazos-Rehg, P., Sobell, J. L., Knowles, J. A., … Genomic Psychiatry Cohort Consortium. (2014). Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry, 71(3), 248–254. doi:10.1001/jamapsychiatry.2013.3726
   PubMed Web of Science ®Google Scholar
• Hodgins, D. C., & el-Guebaly, N. (1992). More data on the Addiction Severity Index. Reliability and validity with the mentally ill substance abuser. Journal of Nervous and Mental Disease, 180(3), 197–201. doi:10.1097/00005053-199203000-00009
   PubMed Web of Science ®Google Scholar
• Kelly, T. M., & Daley, D. C. (2013). Integrated treatment of substance use and psychiatric disorders. Social Work in Public Health, 28(3–4), 388–406. doi:10.1080/19371918.2013.774673
   PubMed Web of Science ®Google Scholar
• Kosten, T. R., Rounsaville, B. J., & Kleber, H. D. (1983). Concurrent validity of the Addiction Severity Index. Journal of Nervous and Mental Disease, 171(10), 606–610. doi:10.1097/00005053-198310000-00003
   PubMed Web of Science ®Google Scholar
• Krawczyk, N., Feder, K. A., Saloner, B., Crum, R. M., Kealhofer, M., & Mojtabai, R. (2017). The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. Drug and Alcohol Dependence, 175, 157–163. doi:10.1016/j.drugalcdep.2017.02.006
   PubMed Web of Science ®Google Scholar
• Lee, J. D., Nunes, E. V., Jr., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., … Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. Lancet, 391(10118), 309–318. doi:10.1016/S0140-6736(17)32812-X
   PubMed Web of Science ®Google Scholar
• Ling, W., Jacobs, P., Hillhouse, M., Hasson, A., Thomas, C., Freese, T., … Tai, B. (2010). From research to the real world: Buprenorphine in the decade of the Clinical Trials Network. Journal of Substance Abuse Treatment, 38 Suppl 1, S53–S60. doi:10.1016/j.jsat.2010.01.009
   PubMed Web of Science ®Google Scholar
• Longabaugh, R., & Wirtz, P. W. (2001). Project MATCH hypotheses: Results and causal chain analyses. In M. E. Mattson & J. K. Myers (Eds.), Project MATCH Monograph Series (Vol. 8). Rockville, MA: US Deparment of Health and Human Services, Public Health Service, National Institute of Health.
   Google Scholar
• Magidson, J. F., Liu, S. M., Lejuez, C. W., & Blanco, C. (2012). Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample. Journal of Psychiatric Research, 46(5), 659–666. doi:10.1016/j.jpsychires.2012.02.011
   PubMed Web of Science ®Google Scholar
• Majer, J. M., Komer, A. C., & Jason, L. A. (2015). Psychiatric severity and HIV-risk sexual behaviors among persons with substance use disorders. Journal of Dual Diagnosis,, 11(1), 3–11. doi:10.1080/15504263.2014.990802
   PubMed Web of Science ®Google Scholar
• Makela, K. (2004). Studies of the reliability and validity of the Addiction Severity Index. Addiction, 99(4), 398–418. doi:10.1111/j.1360-0443.2003.00665.x
   PubMed Web of Science ®Google Scholar
• McCarty, D., Fuller, B., Kaskutas, L. A., Wendt, W. W., Nunes, E. V., Miller, M., … Edmundson, E. (2008). Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug and Alcohol Dependence, 92(1–3), 200–207. doi:10.1016/j.drugalcdep.2007.08.004
   PubMed Web of Science ®Google Scholar
• McDermott, P. A., Alterman, A. I., Brown, L., Zaballero, A., Snider, E. C., & McKay, J. R. (1996). Construct refinement and confirmation for the Addiction Severity Index. Psychological Assessment, 8(2), 182–189. doi:10.1037/1040-3590.8.2.182
   Web of Science ®Google Scholar
• McGahan, P. L., Griffith, J. A., Parente, R., & McLellann, A. T. (1986). Addiction Severity Index composite scores manual. Retrieved from http://tresearch.org/images_specific/CompositeManual.pdf
   Google Scholar
• McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., … Argeriou, M. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9(3), 199–213. doi:10.1016/0740-5472(92)90062-S
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Luborsky, L., Woody, G. E., & O’Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. The Journal of Nervous and Mental Disease, 168(1), 26–33. doi:10.1097/00005053-198001000-00006
   PubMed Web of Science ®Google Scholar
• Najt, P., Fusar-Poli, P., & Brambilla, P. (2011). Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes. Psychiatry Research, 186(2–3), 159–164. doi:10.1016/j.psychres.2010.07.042
   PubMed Web of Science ®Google Scholar
• Parikh, R., Mathai, A., Parikh, S., Chandra Sekhar, G., & Thomas, R. (2008). Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology, 56(1), 45–50. doi:10.4103/0301-4738.37595
   PubMed Web of Science ®Google Scholar
• Peirce, J. M., Petry, N. M., Stitzer, M. L., Blaine, J., Kellogg, S., Satterfield, F., … Li, R. (2006). Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry, 63(2), 201–208. doi:10.1001/archpsyc.63.2.201
   PubMed Web of Science ®Google Scholar
• Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013). Current status of co-occurring mood and substance use disorders: A new therapeutic target. American Journal of Psychiatry, 170(1), 23–30. doi:10.1176/appi.ajp.2012.12010112
   PubMed Web of Science ®Google Scholar
• Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511–2518. doi:10.1001/jama.1990.03450190043026
   PubMed Web of Science ®Google Scholar
• Ross, S., Dermatis, H., Levounis, P., & Galanter, M. (2003). A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. American Journal of Drug and Alcohol Abuse, 29(2), 263–279. doi:10.1081/ADA-120020511
   PubMed Web of Science ®Google Scholar
• Ross, S., & Peselow, E. (2012). Co-occurring psychotic and addictive disorders: Neurobiology and diagnosis. Clinical Neuropharmacology, 35(5), 235–243. doi:10.1097/WNF.0b013e318261e193
   PubMed Web of Science ®Google Scholar
• Rowe, C. L., Liddle, H. A., Greenbaum, P. E., & Henderson, C. E. (2004). Impact of psychiatric comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment, 26(2), 129–140. doi:10.1016/S0740-5472(03)00166-1
   PubMed Web of Science ®Google Scholar
• Rush, B., Castel, S., Brands, B., Toneatto, T., & Veldhuizen, S. (2013). Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders. Journal of Substance Abuse Treatment, 44(4), 375–383. doi:10.1016/j.jsat.2012.08.221
   PubMed Web of Science ®Google Scholar
• Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., … Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 Suppl 20, 22–57.
   PubMed Web of Science ®Google Scholar
• Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1995). The Structured Clinical Interview for the DSM-IV (SCID). Washington, DC: American Psychiatric Press.
   Google Scholar
• StataCorp. (2015). Stata statistical software: Release 14. College Station, TX: StataCorp LP.
   Google Scholar
• Stein, L. A., Clair, M., Lebeau, R., Colby, S. M., Barnett, N. P., Golembeske, C., & Monti, P. M. (2011). Motivational interviewing to reduce substance-related consequences: Effects for incarcerated adolescents with depressed mood. Drug and Alcohol Dependence, 118(2–3), 475–478. doi:10.1016/j.drugalcdep.2011.03.023
   PubMed Web of Science ®Google Scholar
• Susukida, R., Crum, R. M., Stuart, E. A., Ebnesajjad, C., & Mojtabai, R. (2016). Assessing sample representativeness in randomized controlled trials: Application to the National Institute of Drug Abuse Clinical Trials Network. Addiction, 111(7), 1226–1234. doi:10.1111/add.13327
   PubMed Web of Science ®Google Scholar
• Tai, B., Straus, M. M., Liu, D., Sparenborg, S., Jackson, R., & McCarty, D. (2010). The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment, 38 Suppl 1, S4–S13. doi:10.1016/j.jsat.2010.01.011
   PubMed Web of Science ®Google Scholar
• Torrens, M., Serrano, D., Astals, M., Perez-Dominguez, G., & Martin-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry, 161(7), 1231–1237. doi:10.1176/appi.ajp.161.7.1231
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., Potter, J. S., Griffin, M. L., Provost, S. E., Fitzmaurice, G. M., McDermott, K. A., … Carroll, K. M. (2015). Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug and Alcohol Dependence, 150, 112–119. doi:10.1016/j.drugalcdep.2015.02.030
   PubMed Web of Science ®Google Scholar